Xcel Peptides review

A gate, and what stands in front of it

Xcel Peptides, a trade name of Xcel Research LLC, operates from Sheridan, Wyoming, and shows the public a single thing: a sign-in wall. Every page we fetched, including the home, shop, product, lab-tests, returns and contact pages, rendered the same gate reading “Sign in to access the Research Use Only catalog.” What survives in public view is the legal entity line, a “99% Purity Guaranteed” statement, a “USA-Based Company” claim, and the assertion that “Every batch undergoes rigorous third-party laboratory testing to verify purity and molecular identity before release.” A research-use-only disclaimer is present. The company also carries an FDA warning letter dated December 10, 2024, and a reader learns more about who runs the store from that letter than from the store.

We fetched the homepage, the shop, the lab-tests page, the refund and returns page and the contact page, read the warning letter on fda.gov, checked for a Trustpilot profile and read the PeptideProtocolWiki entry. Everything below comes from those sources or from public records.

What can be said about testing

The company claims third-party testing of every batch and describes its documentation only as “Comprehensive Multiple Labs reports.” No laboratory is named on any accessible page, and the /lab-tests/ page sits behind the same gate as everything else, so certificates are recorded as not public. HPLC, mass spectrometry, endotoxin, sterility and per-lot coverage are all unknown. PeptideProtocolWiki, a third-party source, attributes the testing to Janoshik, but we could not confirm that on the vendor’s site and it is excluded from the structured record. The 99 percent purity guarantee is the only policy a reader can see, and there is no document to measure it against.

In plain terms, a buyer is asked to accept a testing claim, a purity guarantee and a vendor identity on the strength of three sentences, and to sign in to learn anything further. Many gated suppliers at least name their laboratory on the public side so that a reader can decide whether registering is worth the trouble. Xcel does not, and the phrase it uses instead, “Multiple Labs,” names nobody.

The warning letter, the company and what is hidden

The FDA issued a warning letter dated 2024-12-10 to Xcel Research LLC, available at https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/xcel-research-llc-694608-12102024. Following a website review in October 2024, it names seven products that the agency considers unapproved new drugs, and it states that “FOR RESEARCH USE ONLY” labeling does not change the intended use of those products. That last point is directed at the entire research-chemical market, not only at this company, and it is worth reading in the agency’s own words.

The site shows no email, no phone and no street address. The address in our record, 1309 Coffeen Ave., Suite 12238, Sheridan, WY 82801, and the support email both come from the FDA letter. No Trustpilot profile exists for xcelpeptides.com, no founding year is published and no certification is claimed. The gap between the regulatory record and the site’s public face is the notable feature here: the agency identifies the operator, its address and its support email, while the site identifies only a trade name and a parent LLC.

Vials are the only format recorded. Listings seen before the gate include SERMORELIN, AOD-9604 and several GLP-class products listed under short brand names, along with two sizes of a mixing solution. The product count, every price and the BPC-157 benchmark are unknown. PeptideProtocolWiki describes card, PayPal, crypto and eCheck payments, free domestic shipping over $99 and additional formats; none of that was confirmed on the vendor site, and we do not treat it as fact.

Payment methods, carriers, turnaround, international availability and return terms all sit behind the login. A buyer who signs in to see them has already given the company an email address and agreed to terms they could not read in advance, which is the reverse of the order in which a careful purchaser wants to do things.

Set against the field, Xcel Peptides belongs with the login-walled suppliers, and within that group it discloses the least. The others we track at least name a laboratory, state a payment method or publish a working address on the public side, so that a reader has something to weigh before registering. Xcel offers a trade name, a parent LLC and two sentences of assurance. The FDA letter supplies the address, the support email and the product list, which is to say that the agency has done the disclosure the company has not. A buyer who wants to know who they are dealing with should read the letter first and the website second, and they will find the letter more informative on every point.

The letter’s language about research-use labeling also deserves attention beyond this one company. The agency stated, in writing and about these specific products, that a “FOR RESEARCH USE ONLY” label does not change what it considers the intended use to be. That is a position the FDA has taken with several suppliers in this market, and it is the clearest statement of it in our set. Readers evaluating any gated storefront should understand that the label on the vial is not, in the agency’s view, the end of the question.

Bottom line

Xcel Peptides shows the public a legal entity name, a purity guarantee and a testing claim, and nothing that would let anyone check any of the three. Catalog, prices, certificates, laboratory names, contact details and policies are all withheld, and a December 2024 FDA warning letter, which names the products the company sells and rejects its research-use labeling as a defense, sits on the record. The named entity is the one concrete fact a reader can take from the site without signing in. We would not register to learn the rest, and we see no category of buyer for whom this record argues otherwise.